non squamous non small cell lung cancer

Showing 1 - 3 of 3

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Squamous Non Small Cell Lung Cancer, EGFR Positive NSCLC Trial (Toripalimab plus Chemotherapy)

Not yet recruiting
  • Non Squamous Non Small Cell Lung Cancer
  • EGFR Positive Non-small Cell Lung Cancer
  • Toripalimab plus Chemotherapy
  • (no location specified)
Jul 28, 2023

Non Squamous Non Small Cell Lung Cancer Trial in Korea, Republic of (Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin)

Not yet recruiting
  • Non Squamous Non Small Cell Lung Cancer
  • Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin
  • Anam, Korea, Republic of
  • +7 more
May 1, 2023

Non Squamous Non Small Cell Lung Cancer Trial in United States (OGX-427, Placebo)

Completed
  • Non Squamous Non Small Cell Lung Cancer
  • Denver, Colorado
  • +15 more
Jun 6, 2018